Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, is delighted to announce that Dr Sohaib Mir has been promoted to Principal within the Investment Team.

Sohaib qualified in Medicine at the University of Birmingham where he also completed a PhD in CNS regeneration. He practised medicine at Addenbrooke’s Hospital in Cambridge and gained an MPhil in Bioscience Enterprise from the University of Cambridge. Before joining CIC he worked at Perella Weinberg Partners in London within the Healthcare M&A team.

 

Promotion to Principal reflects the contribution that he continues to make to the success of CIC.

Michael Anstey Investment Director, CIC


Sohaib joined CIC in 2014 as its fourth employee. Since joining CIC he has worked with a range of promising companies with a particular emphasis on the life sciences sector. Most recently he led CIC’s investment in PolyProx Therapeutics.

Michael Anstey, Investment Director at CIC, said, “Over the last five years Sohaib has proved himself to be an invaluable member of the CIC team, possessing the essential mix of scientific knowledge and practical application to the issues commonly encountered by our growing businesses.  Promotion to Principal reflects the contribution that he continues to make to the success of CIC.”